For years, migraines have been the subject of extensive research, as their symptoms significantly burden individuals' quality of life. Existing treatments primarily rely on pharmaceutical interventions targeting various symptoms associated with migraines. However, the varying efficacy and side effects of these medications have led to the consideration of alternative treatment modalities to improve patient outcomes and minimize adverse effects. This case study investigates the efficacy of osteopathic manipulative treatment (OMT) for the management of chronic migraines in a 27-year-old female patient. This patient presented with a history of debilitating migraines with auras that began in 2018. She had previously tried various medications for migraine prophylaxis with limited success. After years of poorly controlled migraines, she decided to enroll in a clinical trial that required an abrupt discontinuation of her previous treatment involving a medication washout period. During this time, her symptoms worsened and significantly impacted her ability to perform activities of daily living (ADL). Additionally, during this time, she received a single OMT treatment. Following this treatment, she reported immediate improvement, including a reduction in migraine frequency and elimination of nausea and visual auras. This case study highlights the benefit of incorporating OMT as an effective treatment for chronic migraines, providing substantial relief and symptom reduction for one month. The incorporation of OMT alongside pharmacological treatments may provide comprehensive care to patients suffering from chronic migraines, thus enhancing their quality of life and alleviating the global burden of this medical condition.
Keywords: activities of daily life; failed medication therapy; headache relief; manual modality; migraine-type headache; non-pharmacological treatment; osteopathic manipulative medicine (omm); osteopathic manipulative treatment (omt); preventive intervention; refractory headache.
Copyright © 2025, Lahlou et al.